NuWays AG Affirms "Buy" Rating for NanoRepro AG Amidst Strategic Developments

NuWays AG has reaffirmed its "Buy" recommendation for NanoRepro AG, setting a target price of EUR 4.3 over the next 12 months. This comes after NanoRepro announced an increase in its equity stake in Deutsche Kosmetikwerke (DKW), enhancing its multi-brand strategy. The stake rose from 11.01% to 22.7%, with an indirect hold of 21.03% via Paedi Protect AG, totaling a 43.72% share in DKW, positioning NanoRepro favorably in the athletic skincare market projected to grow at a 12.2% CAGR until FY28.

NanoRepro also reported preliminary FY25 revenue figures, revealing total consolidated revenues of EUR 16 million, surpassing the guidance range of EUR 13-15 million. Rapid testing kits and nutritional elixirs recorded a slight decline to EUR 4.3 million, while skincare products under PAEDIPROTECT saw a 1.7% revenue increase. Notably, non-consolidated revenue from athletic skincare sales grew by 37%, reaching EUR 2.6 million.

Looking forward, NanoRepro expects FY26 sales to reach EUR 17.6 million, with strategic growth initiatives underway, signaling a promising trajectory.